Invention Grant
- Patent Title: Anti-CLL-1 antibodies and methods of use
-
Application No.: US16658706Application Date: 2019-10-21
-
Publication No.: US11466087B2Publication Date: 2022-10-11
- Inventor: Robert F. Kelley , Steven R. Leong , Wei-Ching Liang , Mary Mathieu , Andrew G. Polson , Bing Zheng , Xiaocheng Chen , Cecilia Pui Chi Chiu , Mark S. Dennis , Allen Ebens , Yan Wu
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Clark & Elbing LLP
- Agent Thomas J. Takara
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07K16/30 ; A61K45/06 ; A61K39/00
Abstract:
The present invention relates to anti-CLL-1 antibodies including anti-CLL-1 antibodies comprising a CLL-1 binding domain and a CD3 binding domain (e.g., anti-CLL-1/CD3 T cell dependent bispecific (TDB) antibody) and methods of using the same.
Public/Granted literature
- US20200148774A1 Anti-CLL-1 Antibodies and Methods of Use Public/Granted day:2020-05-14
Information query
